Alpha-1-antitrypsin deficiency, the serpinopathies and conformational disease

Journal of the Royal College of Physicians of London

Volumn 34, Issue 3, 2000, Pages 295-300

  Parmar, Jas S ^a   Lomas, David A ^b  

^a WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTICHYMOTRYPSIN; ALPHA 1 ANTITRYPSIN; ANTITHROMBIN; COMPLEMENT COMPONENT C1S INHIBITOR; CORTICOSTEROID; RETINOIC ACID; SERINE PROTEINASE INHIBITOR;

AMYLOIDOSIS; ANGIONEUROTIC EDEMA; ARTICLE; CELL INCLUSION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL FEATURE; CLINICAL TRIAL; CREUTZFELDT JAKOB DISEASE; DEMENTIA; EMPHYSEMA; HUMAN; HUNTINGTON CHOREA; LIVER CELL; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; META ANALYSIS; POINT MUTATION; POLYMERIZATION; PROTEIN CONFORMATION; PROTEIN DEFICIENCY; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; THROMBOSIS;

ALPHA 1-ANTITRYPSIN; ALPHA 1-ANTITRYPSIN DEFICIENCY; AMYLOIDOSIS; CREUTZFELDT-JAKOB SYNDROME; HUMANS; HUNTINGTON DISEASE; INCLUSION BODIES; POLYMERS; PROTEIN CONFORMATION; SERPINS;

EID: 0033918229     PISSN: 00358819     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (60)

1. Kiernan V. Warm hearts in a cold land. New Scientist 4 March 1995:10.
2. Kuzemko JA. Chopin's illnesses. J R Soc Med 1994;87:769-72.
3. Kubba AK, Young M. The long suffering of Frederic Chopin. Chest 1997;113:210-6.
4. 1-antitrypsin deficiency. Scand J Clin Lab Invest 1963;15:132-40.
5. Beatty K, Bieth J, Travis J. Kinetics of association of serine proteinases with native and oxidized α-1-proteinase inhibitor and α-1-antichymotrypsin. J Biol Chem 1980;255:3931-4.
6. 1-antitrypsin. Nature 1982;298:329-34.
7. 1-antitrypsin deficiency. Acta Med Scand 1965;432(Suppl):1-85.
8. Mahadeva R, Lomas DA. Alpha1-antitrypsin deficiency, cirrhosis and emphysema. Thorax 1998;53: 501-5.
9. 1-antitrypsin in Puerto Rican children with asthma. Chest 1993;103:812-5.
10. 1-antitrypsin deficiency: evaluation of bronchiectasis with CT. Radiology 1996;199:137-41.
11. Griffith ME, Lovegrove JU, Gaskin G, Whitehouse DB, Pusey CD. C-antineutrophil cytoplasmic antibody positivity in vasculitis patients is associated with the Z allele of alpha-1-antitrypsin, and P-antineutrophil cytoplasmic antibody positivity with the S allele. Nephrol Dial Transplant 1996;11:438-43.
12. Brantly M, Nukiwa T, Crystal RG. Molecular basis of alpha-1-antitrypsin deficiency. Am J Med 1988;84(Suppl 6A):13-31.
13. 1-antitrypsin. Biochim Biophys Acta 1976;453:257-61.
14. 1-antitrypsin PiZ. FEBS Lett 1976;65:195-7.
15. Yoshida A, Lieberman J, Gaidulis L, Ewing C. Molecular abnormality of human alpha 1-antitrypsin variant (Pi-ZZ) associated with plasma activity deficiency. Proc Natl Acad Sci USA 1976;73:1324-8.
16. Sveger T. Liver disease in alpha 1-antitrypsin deficiency detected by screening of 200,000 infants. N Engl J Med 1976;294:1316-21.
17. 1-antitrypsin deficient children. Acta Paediatr Scand 1988;77:847-51.
18. Eriksson S, Carlson J, Velez R. Risk of cirrhosis and primary liver cancer in alpha 1-antitrypsin deficiency. N Engl J Med 1986;314: 736-9.
19. Potempa J, Korzus E, Travis J. The serpin superfamily of proteinase inhibitors: structure, function, and regulation. J Biol Chem 1994; 269:15957-60.
20. 1-antitrypsin for structure and function of serpins. Biochemistry 1989;28:8951-66.
21. Whisstock JC, Skinner R, Lesk AM. An atlas of serpin conformations. Trends Biochem Sci 1998;23:63-7.
22. Johnson D, Travis J. Structural evidence for methionine at the reactive site of human α-1-proteinase inhibitor. J Biol Chem 1978; 253:7142-4.
23. Stratikos E, Gettins PGW. Major proteinase movement upon stable serpin-proteinase complex formation. Proc Natl Acad Sci USA 1997;4:453-8.
24. Wilczynska M, Fa M, Karolin J, Ohlsson P-I, et al. Structural insights into serpin-protease complexes reveal the inhibitory mechanism of serpins. Nat Struc Biol 1997;4:354-7.
25. 2-antiplasmin, angiotensinogen, and ovalbumin. Biochemistry 1991;30:1723-30.
26. 1-antitrypsin accumulation in the liver. Nature 1992;357:605-7.
27. 1-antitrypsin. Biochemistry 1993;32:500-8.
28. 1-antitrypsin. Nat Struc Biol 1996;3:676-81.
29. 1-antitrypsin is in the canonical inhibitory conformation. Review. J Mol Biol 1998;275: 419-25.
30. Skinner R, Chang W-SW, Jin L, Pei X, et al. Implications for function and therapy of a 2.9 Å structure of binary-complexed antithrombin. J Mol Biol 1998;283:9-14.
31. 1-antitrypsin deficiency in Japan. Am Rev Respir Dis 1995;152:2119-26.
32. Roberts EA, Cox DW, Medline A, Wanless IR. Occurrence of alpha-1-antitrypsin deficiency in 155 patients with alcoholic liver disease. Am J Clin Pathol 1984;82:424-7.
33. 53→Phe). Further evidence for intracellular loop-sheet polymerisation. J Biol Chem 1993;268:15333-5.
34. 52Phe deleted) forms loop-sheet polymers in vivo: evidence for the C sheet mechanism of polymerisation. J Biol Chem 1995;270:16864-70.
35. 1-antitrypsin. J Biol Chem 1999;274:9548-55.
36. 1-antitrypsin deficiency. Proc Natl Acad Sci USA 1994;91:9014-8.
37. 1-antitrypsin Z and S is distinct from that for an unassembled membrane protein. J Biol Chem 1996;271:13215-20.
38. 1-antitrypsin deficiency in early childhood. Pediatrics 1978;62:22-5.
39. 1-antitrypsin. Nat Struc Biol 1996;3:910-1.
40. 1-antitrypsin and liver cirrhosis. J Clin Invest 1999;103:999-1006.
41. Piitulainen E, Eriksson S. Decline in FEV1 related to smoking status in individuals with severe alpha1-antitrypsin deficiency. Eur Respir J 1999;13:247-51.
42. Larsson C. Natural history and life expectancy in severe alpha1-antitrypsin deficiency, PiZ. Acta Med Scand 1978;204:345-51.
43. 1-antitrypsin related emphysema. Am J Respir Cell Mol Biol 1998;18:670-4.
44. 436→Thr) results in nonsubstrate-like behavior and in polymerization of the molecule. J Biol Chem 1993;268:18088-94.
45. Eldering E, Verpy E, Roem D, Meo T, Tosi M. COOH-terminal substitutions in the serpin C1 inhibitor that cause loop over-insertion and subsequent multimerization. J Biol Chem 1995;270: 2579-87.
46. Bruce D, Perry DJ, Borg J-Y, Carrell RW, Wardell MR. Thromboembolic disease due to thermolabile conformational changes of antithrombin Rouen-VI (187 AsnvAsp). J Clin Invest 1994;94: 2265-74.
47. 382 to Thr) causing severe thromboembolic tendency undergoes the S-to-R transition and is associated with a plasma-inactive high-molecular-weight complex of aggregated antithrombin. Br J Haematol 1995;89:589-601.
48. 1-antichymotrypsin allele associated with familial obstructive lung disease. Genomics 1993;17:740-3.
49. 1-antichymotrypsin deficiency in a heterozygote with liver and lung disease. J Hepatol 1993;18:313-21.
50. 1-antichymotrypsin indicates two stage insertion of the reactive loop; implications for inhibitory function and conformational disease. Proc Natl Acad Sci USA 2000; 97:67-72.
51. Davis RL, Shrimpton AE, Holohan PD, Bradshaw C, et al. Familial dementia caused by polymerisation of mutant neuroserpin. Nature 1999;401:376-9.
52. Wewers MD, Casolaro MA, Sellers SE, Swayze SC, et al. Replacement therapy for alpha1-antitrypsin deficiency associated with emphysema. N Engl J Med 1987;316:1055-62.
53. 1-antitrypsin. Am J Respir Crit Care Med 1998;158:49-59.
54. 1-antitrypsin augmentation therapy. Am J Resp Crit Care Med 1999;160:1468-72.
55. Massaro GD, Massaro D. Retinoic acid treatment abrogates elastase-induced pulmonary emphysema in rats. Nat Med 1997;3:675-7.
56. Carrell RW, Lomas DA. Conformational diseases. Lancet 1997;350: 134-8.
57. Perutz MF. Glutamine repeats and inherited neurodegenerative diseases: molecular aspects. Curr Opin Struc Biol 1996;6:848-58.
58. Davis-Salinas J, Van Nostranel WE. Amyloid β-protein aggregation nullifies its pathogenic properties in cultured cerebrovascular smooth muscle cells. J Biol Chem 1995;270:20887-90.
59. Prusiner SB. Prion diseases of humans and animals. J R Coll Physicians Lond 1994;28:1-30.
60. Soto C, Sigurdsson EM, Morelli L, Kumar RA, et al. β-sheet breaker peptides inhibit fibrillogenesis in a rat brain model of amyloidosis: implications for Alzheimer's therapy. Nat Med 1998;4:822-6.